Page last updated: 2024-08-26

22-hydroxycholesterol and Prostatic Neoplasms

22-hydroxycholesterol has been researched along with Prostatic Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Gao, X; Gong, H; Khadem, S; Lee, JH; Li, S; Lu, Y; Xie, W; Zhang, J	1

Other Studies

1 other study(ies) available for 22-hydroxycholesterol and Prostatic Neoplasms

Article	Year
Androgen deprivation by activating the liver X receptor. Endocrinology, 2008, Volume: 149, Issue:8 Topics: Androgens; Animals; Benzoates; Benzylamines; Cells, Cultured; DNA-Binding Proteins; Drug Resistance, Neoplasm; Gene Expression Regulation, Enzymologic; Humans; Hydroxycholesterols; Liver X Receptors; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Neoplasms, Hormone-Dependent; Orphan Nuclear Receptors; Prostate; Prostatic Neoplasms; Receptors, Cytoplasmic and Nuclear; Regeneration; Sulfotransferases; Testosterone	2008

Article

Year

Androgen deprivation by activating the liver X receptor.

Endocrinology, 2008, Volume: 149, Issue:8

Topics: Androgens; Animals; Benzoates; Benzylamines; Cells, Cultured; DNA-Binding Proteins; Drug Resistance, Neoplasm; Gene Expression Regulation, Enzymologic; Humans; Hydroxycholesterols; Liver X Receptors; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Neoplasms, Hormone-Dependent; Orphan Nuclear Receptors; Prostate; Prostatic Neoplasms; Receptors, Cytoplasmic and Nuclear; Regeneration; Sulfotransferases; Testosterone

2008